A lthough U.S. regulators approved several new antibiotics for combating hard-to-treat bacteria during a recent five-year ...

With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help ...

Millions of Americans struggling with obesity need ways to lose weight that benefit the body as a whole, not just whittle ...

How does a startup compete in the rapidly evolving field of weight loss drugs? And how did a major telemedicine company fall ...

Our latest edition of D.C. Diagnosis includes the backstory of BIO's relationship with WuXi, a major endorsement of ...

Imagine that your favorite independent coffee shop is bought by a global chain. Your $2 cup of joe jumps to $4 overnight.

But experts know the new nets are a limited solution, as they expect mosquitos to eventually become resistant to the ...

A new analysis of health inequities shows that every state has deep racial and ethnic disparities in the performance of their ...

Cerevel Therapeutics, which AbbVie is acquiring, said Thursday its drug tavapadon, taken with the common Parkinson's drug ...

Amylyx Pharmaceuticals recently said it would pull its ALS drug Relyvrio from the market. After taking a look at a slide deck ...

As lawmakers take aim at WuXi Apptec, the issue is testing the ability of BIO's CEO to navigate a domestic policy issue that ...

A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 ...